Clinical Trials Logo

Heart Failure, Diastolic clinical trials

View clinical trials related to Heart Failure, Diastolic.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02155842 Withdrawn - Clinical trials for Heart Failure, Diastolic

Exercise Training in Treating Diastolic Heart Failure

TREND-HF
Start date: June 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether endurance exercise of either high or moderate intensity can reverse structural and functional changes of the heart in patients with diastolic heart failure, and to investigate which type of exercise is best in terms of aerobe capacity and quality of life. The investigators expect that high intensity endurance exercise is superior to moderate intensity endurance exercise.

NCT ID: NCT00773084 Withdrawn - Clinical trials for Diastolic Heart Failure

Aliskiren and Renin Inhibition in Diastolic Heart Failure

ARID-HF
Start date: September 2008
Phase: N/A
Study type: Interventional

This study is being conducted to compare the effects that 2 different combinations of heart failure medications have on the levels of certain blood markers which cause and/or worsen heart failure. Additionally, the investigators will investigate any differences that may exist between Hispanics and Non-Hispanics. The investigators hope to find that Hispanic Americans will have a greater response to this new regimen compared to non-Hispanic Americans.

NCT ID: NCT00757055 Withdrawn - Clinical trials for Diastolic Heart Failure

If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure

Start date: December 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate whether the medicine ivabradine, a novel drug which slows the heart rate has a favourable effect on patients with diastolic heart failure. Ivabradine is a specific heart rate-lowering agent. It has a licence for treating patients with angina who are intolerant of agents such as beta blockers or whose angina is not adequately controlled. It has been shown to prolong exercise tolerance in these patients and to reduce the frequency of chest pain. Its mechanism of action is felt to be purely due to reducing heart rate, by as much as 10 beats per minute at rest, as well as by reducing the heart rate response to exercise. Patients with diastolic heart failure often complain of breathlessness on exertion which relates to the stiffness or lack of compliance of their heart i.e. the heart fails to relax rapidly enough to allow it to fill with blood between each heart beat. This may result in high pressure in the heart chamber which backs up in to the lungs and may be experienced as breathlessness. There is little evidence that any specific therapy benefits patients with this type of heart failure besides treating coexisting problems such as high blood pressure or angina. By slowing the heart rate down with ivabradine, the heart would have a longer time to fill during exercise which would make it more effective. This slowing of the heart rate may therefore relieve the breathlessness experienced on activity such as walking to the shops or up a flight of stairs etc.